Skip to main content

Profiles

Eli Lilly

Eli Lilly

Eli Lilly & Company, commonly known as Eli Lilly or simply Lilly, is an American pharmaceutical company based in Indianapolis, Indiana.

History

In August 2017, Ophirex announced it had licensed data around sPLA2 inhibitors from Eli Lilly and Shionogi.[1]

Eli Lilly was a sponsor for BioFIT 2017.[2]

On May 28, 2019, Lilly announced an exclusive worldwide licensing agreement with Centrexion Therapeutics for CNTX-0290, a novel, small molecule somatostatin receptor type 4 (SSTR4) agonist. At the time of the deal, it was in clinical trials as a potential non-opioid treatment for chronic pain conditions.[3]

Lilly was also developing a product with BioNTech as of 2019.[4]

COVID-19

During the declared COVID-19 pandemic, Eli Lilly received Emergency Use Authorizations (EUA) from the Food and Drug Administration (FDA) for three experimental COVID-19 drugs: Bamlanivimab, Etesevimab and Olumiant (in combination with remdesivir).[5][6]

In March 2020, Eli Lilly joined the COVID-19 Therapeutics Accelerator, funded by the Bill & Melinda Gates Foundation, Wellcome Trust, and Mastercard, to “accelerate treatments, vaccines, and diagnostics.”[7] As part of the accelerator, the company receiving funding from the Bill & Melinda Gates Foundation Strategic Investment Fund (SIF) "to facilitate access to future Lilly therapeutic antibodies under development for the prevention and treatment of COVID-19 for low- and middle-income countries."[8]

The company also joined the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership, launched on April 17, 2020, as an industry leadership organization.[9]

In June 2020, Eli Lilly announced it Shad begun the world's first study of a potential antibody treatment against COVID-19, with a Phase 1 trial of LY-CoV555 (Bamlanivimab), in collaboration with AbCellera.[10]

In September 2020, Amgen announced that the company had partnered with Eli Lilly to manufacture COVID-19 antibody therapies.[11]

Bamlanivimab was granted an EUA in November 2020, which was subsequently renewed in February and March 2021.[12][6:1]

On February 10, 2022, AbCellera announced an agreement between the United States Federal Government and Eli Lilly to purchase "up to 600,000 doses, for at least $720 million," of Bebtelovimab, a monoclonal antibody.[13]

On January 14, 2025, Andreessen Horowitz (a16z) announced the launch of the Biotech Ecosystem Venture Fund (BEVF) as a partnership between a16z Bio + Health and Eli Lilly.[14]

Organization

As of September 2023, 10% of Eli Lilly's stock is owned by the Lilly Endowment.[15]

Eli Lilly has been a client of Antibody Healthcare Communications,[16] Coates & Jarratt,[17] FCB Health Canada,[18] FrogueClark,[19] Invariant,[20] Leger Marketing,[21] Outpost379[22] the Pharmaceutical Advertising Advisory Board (PAAB),[23] Speakers' Spotlight,[24] STI Technologies[25] and Trois Prime.[26]

Personnel

Name Position Notes
David Ricks Chief Executive Officer -
Andrew Charles Adams Chief Scientific Officer[27] Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
Mitch Daniels Senior Vice President, Corporate Strategy and Policy (former)[28] Hudson Institute, National Resilience, COVID Collaborative
Carlos Garner Senior Vice President, Global Regulatory Affairs[29] Franklin Township Community School Corporation (FTCSC), Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
Kathryn Dickey Karol Assistant Vice President of Global Government Affairs (former)[30] International Republican Institute (IRI), Freedom House, Central Intelligence Agency (CIA)
Ajay Nirula Vice President, Immunology[27:1] Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
Carolyn Bertozzi Board Member (former)[31] Colossal Biosciences, Lycia Therapeutics
George H.W. Bush Board Member (former)[32][33] President of the United States, Central Intelligence Agency (CIA)
Stéphane Bancel Head of Operations for Belgium (former)[34] Moderna, bioMérieux, Forum of Young Global Leaders
Patricia Brown-Augsburger Research Fellow[27:2] Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
Carsten Brunn Global Product Team (1998-2005)[35] Selecta Biosciences, Bayer, Novartis, Cartesian Therapeutics
Jean-Cosme Dodart Senior Research Scientist (1999-2006)[36] Vaxxinity, United Neuroscience, Codiak BioSciences
Philip Ebert Principal Research Scientist[27:3] Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
Nicole Kallewaard Research Advisor, Immunology-Translational Sciences[27:4] Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
William Lister Director of Market Research, Pharmaceutical Division (former)[37] Axial Biotech, Roche, Boehringer Mannheim
Ania Mitan Multiple former positions[38] Celgene, Drug Information Association (DIA)
Hélène Decaluwe Scientific Advisory Board member[39] National Advisory Committee on Immunization (NACI)

Subsidiaries and initiatives

  • Eli Lilly and Company Foundation
  • Eli Lilly and Company Political Action Committee
  • Lilly Asia Ventures (LAV)
  • Lilly Foundation
  • Lilly MDR-TB Partnership
  • Lilly Ventures

Memberships

Eli Lilly is a member of:

Partners

Eli Lilly is a partner of:

Activities

Eli Lilly has provided funding to:

  1. Lewin, M. (2017, August 28). Ophirex Licenses Lilly - Shionogi Data for Novel Snakebite Treatment Development Program. Bloomberg. http://archive.today/2022.04.13-100603/https://www.bloomberg.com/press-releases/2017-08-28/ophirex-licenses-lilly-shionogi-data-for-novel-snakebite-treatment-development-program ↩︎

  2. 2017 Participants. BioFIT 2022. Retrieved June 12, 2022, from http://archive.today/2022.06.12-195815/https://www.biofit-event.com/partnering-biofit/2017-participants/ ↩︎

  3. Taylor, M., Hern, K., Normart, J., & Dugan, C. (2019, May 28). Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics. Eli Lilly. https://investor.lilly.com/news-releases/news-release-details/lilly-announces-licensing-agreement-non-opioid-pain-asset ↩︎

  4. Amendment No. 3 to Form F-1 Registration Statement. (2019, October 9). BioNTech; Securities and Exchange Commission. https://web.archive.org/web/20221228202950/https://investors.biontech.de/node/6751/html#toc ↩︎

  5. O’Shaughnessy, J. A., PhD. (2021, December 3). RE: Emergency Use Authorization 094. Eli Lilly. Retrieved December 6, 2021, from http://pi.lilly.com/eua/bam-and-ete-eua-fda-authorization-letter.pdf ↩︎

  6. Hinton, D. M. (2021, July 28). Baricitinib EUA FDA Authorization Letter. Eli Lilly. Retrieved December 6, 2021, from http://pi.lilly.com/eua/baricitinib-eua-fda-authorization-letter.pdf ↩︎ ↩︎

  7. Staines, R. (2020, March 26). Pharma giants including Novartis collaborate on COVID-19 therapies. Pharmaphorum. http://archive.today/2022.01.18-165943/https://pharmaphorum.com/news/collaborate-covid19-therapies/ ↩︎ ↩︎

  8. Portfolio - Page 2. Bill & Melinda Gates Foundation Strategic Innovation Fund. Retrieved September 27, 2023, from https://web.archive.org/web/20230927091305/https://sif.gatesfoundation.org/portfolio/?fwp_paged=2&fwp_per_page=30 ↩︎

  9. ACTIV. National Institutes of Health (NIH). Retrieved April 1, 2022, from http://archive.today/2022.01.11-042823/https://www.nih.gov/research-training/medical-research-initiatives/activ ↩︎ ↩︎

  10. Hebert, N. (2020, June 1). Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment in Humans. Eli Lilly and Company. http://archive.today/2020.07.20-171437/https://investor.lilly.com/news-releases/news-release-details/lilly-begins-worlds-first-study-potential-covid-19-antibody ↩︎

  11. Taylor, M., & Rowland, T. (2020, September 17). Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies. Amgen. http://archive.today/2022.01.12-213722/https://www.amgen.com/newsroom/press-releases/2020/09/lilly-and-amgen-announce-manufacturing-collaboration-for-covid-19-antibody-therapies ↩︎

  12. An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-19. (2020). JAMA, 325(9), 880–881. https://doi.org/10.1001/jama.2020.24415 ↩︎

  13. Yingling, J. (2022, February 10). Lilly to Supply up to 600,000 Doses of AbCellera-Discovered Antibody, Bebtelovimab, to the U.S. Government in Ongoing Effort to Provide COVID-19 Treatments. AbCellera. http://archive.today/2022.05.04-174053/https://www.abcellera.com/news/lilly-bebtelovimab-supply ↩︎

  14. a16z editorial. (2025, January 14). Announcement: Andreessen Horowitz Partners with Lilly to Launch First-of-Its-Kind Biotech Ecosystem Fund. Andreessen Horowitz. https://web.archive.org/web/20250116235339/https://a16z.com/announcement-andreessen-horowitz-partners-with-lilly-to-launch-first-of-its-kind-biotech-ecosystem-venture-fund/ ↩︎

  15. Eli Lilly and Company (LLY) Stock Major Holders. Yahoo Finance. Retrieved January 20, 2024, from http://archive.today/2024.01.20-201503/https://finance.yahoo.com/quote/LLY/holders?p=LLY&guccounter=1 ↩︎

  16. Partners. Antibody Healthcare Communications. Retrieved March 4, 2021, from https://web.archive.org/web/20210304145850/https://antibodyhc.com/partners/ ↩︎

  17. Clients. Coates & Jarratt. Retrieved July 12, 2025, from https://web.archive.org/web/20020204160326/http://www.coatesandjarratt.com/clients.htm ↩︎

  18. Our Clients at FCB Health Canada. FCB Health. Retrieved August 30, 2022, from http://archive.vn/2022.08.31-030655/http://fcbhealth.ca/clients/ ↩︎

  19. FrogueClark Lobbying Profile - 2019. OpenSecrets. Retrieved February 7, 2025, from https://www.opensecrets.org/federal-lobbying/firms/summary?cycle=2019&id=D000075590 ↩︎

  20. Heather Podesta & Partners Lobbying Profile - 2008. OpenSecrets. Retrieved November 22, 2024, from https://www.opensecrets.org/federal-lobbying/firms/summary?cycle=2008&id=d000034396 ↩︎

  21. About. Leger. Retrieved November 16, 2022, from https://web.archive.org/web/20221116080443/https://leger360.com/about/ ↩︎

  22. Home. Outpost379. Retrieved May 18, 2025, from https://web.archive.org/web/20250518233829/https://outpost379.com/ ↩︎

  23. About. Pharmaceutical Advertising Advisory Board. Retrieved January 8, 2018, from http://archive.today/2022.08.29-054034/https://web.archive.org/web/20180108160414/http://www.paab.ca/about.htm ↩︎

  24. Our Clients | Hire a Speaker. Speakers’ Spotlight. Retrieved October 26, 2022, from http://archive.today/2022.10.26-154522/https://www.speakers.ca/our-clients/ ↩︎

  25. Home. STI Technologies Limited. Retrieved September 2, 2022, from https://web.archive.org/web/20220626020749/https://smartsti.com/ ↩︎

  26. Clients. Trois Prime. Retrieved September 3, 2022, from https://archive.ph/HTmQX ↩︎

  27. TRACE Working Group. (2021, June 21). National Institutes of Health. https://web.archive.org/web/20241113202014/https://www.nih.gov/research-training/medical-research-initiatives/activ/trace-working-group ↩︎ ↩︎ ↩︎ ↩︎ ↩︎

  28. RetroIndy: Gov. Mitch Daniels. (2013, February 19). IndyStar. https://web.archive.org/web/20160119122503/http://www.indystar.com/apps/pbcs.dll/article?AID=999980917022 ↩︎

  29. Therapeutics Clinical Working Group. (2022, March 8). National Institutes of Health (NIH). http://archive.today/2023.07.02-204924/https://www.nih.gov/research-training/medical-research-initiatives/activ/therapeutics-clinical-working-group ↩︎

  30. Kathryn Dickey Karol. Freedom House. Retrieved July 13, 2007, from http://archive.today/2007.07.13-020009/http://www.freedomhouse.org/template.cfm?boardmember=42&page=10 ↩︎

  31. McCully, M., & Hern, K. (2021, August 25). Lilly Announces that Professor Carolyn Bertozzi has Resigned from its Board of Directors. PR Newswire; Eli Lilly and Company. http://archive.today/2025.07.13-214714/https://www.prnewswire.com/news-releases/lilly-announces-that-professor-carolyn-bertozzi-has-resigned-from-its-board-of-directors-301362134.html ↩︎

  32. Levine, B. (2004, May). Eli Lilly, Zyprexa, & the Bush Family. Z Magazine. http://archive.today/2019.06.17-172326/http://psychrights.org/articles/LevineLillyandBush.htm ↩︎

  33. Lenzer, J. (2004). Bush plans to screen whole US population for mental illness. BMJ, 328(7454), 1458.1. https://doi.org/10.1136/bmj.328.7454.1458 ↩︎

  34. Garde, D. (2016, September 13). Ego, ambition, and turmoil: Inside one of biotech’s most secretive startups. STAT News. https://web.archive.org/web/20201116154313/https://www.statnews.com/2016/09/13/moderna-therapeutics-biotech-mrna/ ↩︎

  35. Experience | Carsten Brunn. LinkedIn. Retrieved July 12, 2025, from https://www.linkedin.com/in/carsten-brunn-a8b287a/details/experience/ ↩︎

  36. Experience | Jean-Cosme Dodart. LinkedIn. Retrieved October 29, 2024, from https://www.linkedin.com/in/jean-cosme-dodart-5366a45/details/experience/ ↩︎

  37. Olson, E. K. (2008, October 14). Axial Biotech Appoints Retired Roche Diagnostics Executive to Board. BioSpace. http://archive.today/2023.09.09-195917/https://www.biospace.com/article/releases/axial-biotech-appoints-retired-roche-diagnostics-executive-to-board-/ ↩︎

  38. Executive Leadership Team. DIA Global. Retrieved May 28, 2023, from http://archive.today/2023.05.28-201837/https://www.diaglobal.org/en/about-us/leadership-governance/Executive-Leadership-Team ↩︎

  39. Public Health Agency of Canada. (2022, February 25). National Advisory Committee on Immunization (NACI): Membership and representation. Government of Canada. https://web.archive.org/web/20220318105951/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html#fn1-rf ↩︎

  40. Member Logos. Ad Standards. Retrieved September 17, 2021, from https://web.archive.org/web/20210917052119/https://adstandards.ca/about/membership/member-logos/ ↩︎

  41. Membership Directory. AdvaMed. Retrieved April 15, 2024, from http://archive.today/2024.04.15-221222/https://www.advamed.org/membership-join/membership-directory/ ↩︎

  42. List of Members. (2022, March 4). Alliance for a Stronger FDA. http://archive.today/2022.07.08-045902/https://www.strengthenfda.org/members ↩︎

  43. About Us. (2022). Alliance for Competitive Taxation. https://web.archive.org/web/20220701005932/https://actontaxreform.com/about-us/ ↩︎

  44. Members & Profiles. Alliance for Regenerative Medicine. Retrieved October 5, 2022, from http://archive.today/2022.10.05-211734/https://alliancerm.org/members/members-and-profiles/ ↩︎

  45. Members and Observers - BuysafeRx Online. ASOP Global. Retrieved April 18, 2023, from http://archive.today/2023.04.18-220255/https://buysaferx.pharmacy/about-asop-global/members-and-observers-2/ ↩︎

  46. COA Corporate Members. (2023, October 23). AS/COA. http://archive.today/2023.08.22-171902/https://www.as-coa.org/about/coa-corporate-members ↩︎

  47. Member Listings. BIOTECanada. Retrieved December 21, 2021, from https://web.archive.org/web/20211221183627/https://www.biotech.ca/about/member-listings/ ↩︎

  48. BIO Member Directory. Biotechnology Innovation Organization. Retrieved September 30, 2022, from https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory ↩︎

  49. Home. Decentralized Trials & Research Alliance. Retrieved January 18, 2023, from https://web.archive.org/web/20230118082639/https://www.dtra.org/ ↩︎

  50. Corporate Liaison Board. Endocrine Society. Retrieved June 10, 2022, from http://archive.today/2022.06.10-234024/https://www.endocrine.org/membership/corporate-liaison-board ↩︎

  51. GBCHealth Member Directory. GBCHealth. Retrieved January 11, 2023, from http://archive.vn/2023.01.11-041556/https://archive.gbchealth.org/our-coalition/member-directory/ ↩︎

  52. Members of GBN's WorldView Service, 1987-2006. Global Business Network. Retrieved July 5, 2008, from https://web.archive.org/web/20080705015144/http://www.gbn.com/OrganizationsDisplayServlet.srv ↩︎

  53. Members. Global Health Council. Retrieved July 26, 2022, from http://archive.today/2022.07.26-224918/https://globalhealth.org/about-us/members/ ↩︎

  54. Member Companies. Innovative Medicines Canada. Retrieved April 14, 2021, from https://web.archive.org/web/20210414150341/http://innovativemedicines.ca/about/member-companies/ ↩︎

  55. Companies. IFPMA. Retrieved July 1, 2022, from https://web.archive.org/web/20220701150736/https://www.ifpma.org/who-we-are/our-membership/full-members/companies/ ↩︎

  56. Firm directory. Kauffman Fellows. Retrieved September 30, 2022, from https://web.archive.org/web/20220930161909/https://www.kauffmanfellows.org/firmdirectory ↩︎

  57. Our Members. National Health Council. Retrieved April 6, 2022, from https://web.archive.org/web/20220406081753/https://nationalhealthcouncil.org/members/?m_cat=74&m_key= ↩︎

  58. Current NORD Corporate Council Members. NORD (National Organization for Rare Disorders). Retrieved October 12, 2022, from https://web.archive.org/web/20221012043656/https://rarediseases.org/get-involved/corporate-council/current-members/ ↩︎

  59. Members. National Pharmaceutical Council. Retrieved April 6, 2022, from https://web.archive.org/web/20211102074208/https://www.npcnow.org/about/members ↩︎

  60. Members. (2022). Northeast Business Group on Health. https://nebgh.org/wp-content/uploads/2022/05/NEBGH-MemberList-051622b.pdf ↩︎

  61. Current Members. Personalized Medicine Coalition. Retrieved April 6, 2022, from https://web.archive.org/web/20210815032705/https://personalizedmedicinecoalition.org/Members/Current_Members ↩︎

  62. About. PhRMA. Retrieved September 14, 2023, from https://web.archive.org/web/20230914221250/https://phrma.org/About ↩︎

  63. Member Organizations. Research!America. Retrieved April 6, 2022, from http://archive.vn/2022.04.06-092643/https://www.researchamerica.org/about-us/member-organizations ↩︎

  64. SGC Collaborators and Partners. SGC. Retrieved April 9, 2023, from https://web.archive.org/web/20230409220032/https://www.thesgc.org/collaborators ↩︎

  65. Members. The U.S.-U.A.E. Business Council. Retrieved February 22, 2023, from https://web.archive.org/web/20230221031522/https://usuaebusiness.org/mission/members/ ↩︎

  66. Partners. The Arthritis Society. Retrieved May 14, 2022, from http://archive.today/2022.05.14-211808/https://arthritis.ca/about-us/partners ↩︎

  67. Employer Partners. Canadian Centre for Diversity and Inclusion. Retrieved June 25, 2025, from https://web.archive.org/web/20250625232550/https://ccdi.ca/employers/ ↩︎

  68. The Digital Pharma Show 2022. GIANT Health. Retrieved June 15, 2022, from http://archive.today/2022.06.15-232403/https://www.giant.health/the-digital-pharma-show ↩︎

  69. Explore Our Collaborations. (2022). Global Health Progress. https://web.archive.org/web/20220403013206/https://globalhealthprogress.org/explore-our-collaborations/ ↩︎

  70. Partners. HOPE Worldwide. Retrieved May 11, 2022, from http://archive.today/2022.05.11-073959/https://www.hopeww.org/about-us/who-we-are/partners ↩︎

  71. Sponsors and CRO’s. Pinnacle Research Group. Retrieved June 12, 2022, from http://archive.today/2022.06.12-095635/http://www.pinnacletrials.com/sponsors/ ↩︎

  72. Our Corporate Innovation Partners. Plug and Play Tech Center. Retrieved June 6, 2023, from https://web.archive.org/web/20230606002503/https://www.plugandplaytechcenter.com/corporations/partners/ ↩︎

  73. Collaborations. Population Health Research Institute. Retrieved June 12, 2022, from http://archive.today/2022.06.12-052154/https://www.phri.ca/collaborations/ ↩︎

  74. A-Z. (2022). Radcliffe Cardiology. https://web.archive.org/web/20220612062914/https://www.radcliffecardiology.com/products-services/a-z ↩︎

  75. Partner With Us. Rethink Breast Cancer. Retrieved October 7, 2022, from http://archive.today/2022.10.07-061421/https://rethinkbreastcancer.com/support-our-movement/sponsor-us/ ↩︎

  76. UNICEF corporate partners. UNICEF. Retrieved November 14, 2022, from https://web.archive.org/web/20221114221314/https://www.unicef.org/partnerships/corporate/our-partners ↩︎

  77. Home. U.S. Black Chambers. Retrieved February 8, 2023, from https://web.archive.org/web/20230208171934/https://usblackchambers.org/ ↩︎

  78. Nicholson, T. Annual Report 2017-2018 (p. 34). Advance Access & Delivery. Retrieved August 19, 2022, from https://web.archive.org/web/20220819075357/https://static1.squarespace.com/static/54e39cb6e4b096d5269be282/t/5db8580f1754fb314b9eb0a5/1572362300212/Annual+Report+2017-2018_FINAL_Oct+29.pdf ↩︎

  79. How We’re Funded. (2022). Alliance for Aging Research. https://web.archive.org/web/20220715161317/https://www.agingresearch.org/about-us/how-were-funded/ ↩︎

  80. Alliance Supporters. Alliance for Continuing Education in the Health Professions. Retrieved May 11, 2023, from http://archive.today/2023.05.11-035425/https://www.acehp.org/What-We-Do/Alliance-Supporters ↩︎

  81. Associate Members and Financial Supporters. (2022, January). Alliance for Patient Access. https://web.archive.org/web/20220128105843/https://admin.allianceforpatientaccess.org/wp-content/uploads/2022/01/AfPADonorsJanuary2022.pdf ↩︎

  82. Supporters. American Association for Cancer Research (AACR). Retrieved January 29, 2023, from http://archive.today/2023.05.11-051652/https://www.aacr.org/meeting/aacr-annual-meeting-2021/supporters/ ↩︎

  83. Banting Circle Supporters. American Diabetes Association. Retrieved October 19, 2022, from http://archive.today/2022.10.19-172612/https://diabetes.org/about-us/corporate-support/banting-circle-supporters ↩︎

  84. Corporate Support. American Society of Hematology. Retrieved June 10, 2022, from http://archive.vn/2022.06.10-180740/https://www.hematology.org/about/corporate-support ↩︎

  85. Sponsors. American Statistical Association. Retrieved May 29, 2023, from http://archive.today/2023.05.29-190120/https://ww2.amstat.org/meetings/jsm/2022/sponsorlist.cfm ↩︎

  86. Our Supporters. Arthritis Australia. Retrieved June 13, 2022, from http://archive.today/2022.06.13-065711/https://arthritisaustralia.com.au/about-us/our-supporters/ ↩︎

  87. Partnership Opportunities. Arthritis Foundation. Retrieved October 16, 2022, from https://web.archive.org/web/20221016171837/https://www.arthritis.org/partnership ↩︎

  88. Partners & Supporters. Autoimmune Association. Retrieved May 11, 2023, from https://autoimmune.org/about-us/partners-collaborators/?tab=partners ↩︎

  89. 2020-2021 Annual Report. (2021). Bipartisan Policy Center. https://bipartisanpolicy.org/download/?file=/wp-content/uploads/2021/06/BPC-Annual-Report_6.8.pdf ↩︎

  90. The Canadian Consortium on Neurodegeneration in Aging. (2019, September 3). Partner Organizations - CCNA Phase I (2014–2019). CCNA-CCNV. Retrieved March 28, 2022, from http://archive.today/2022.03.28-174537/http://ccna-ccnv.ca/partner-organizations-phase-1/ ↩︎

  91. Donor Recognition. Canadian Foundation for Women’s Health. Retrieved December 8, 2002, from https://web.archive.org/web/20021208125530/http://www.cfwh.org/recog_donor_e.html ↩︎

  92. Advertisers’ Index. (2004). Canadian Journal of Emergency Medicine, 6(3), 146. Canadian Association of Emergency Physicians. https://web.archive.org/web/20220618035456/http://caep.ca/periodicals/Volume_6_Issue_3/Vol_6_Issue_3_Table_of_Contents.pdf ↩︎

  93. Hilliard, R. I. (2011). Inside Stories: The Year in Review 2010-2011 (p. 21). Canadian Paediatric Society. https://web.archive.org/web/20230626213917/https://cps.ca/uploads/publications/AnnualReport-2010-2011-en.pdf ↩︎

  94. 2020-2021 Annual Report. (2021). Canadian Rheumatology Association. https://web.archive.org/web/20220301043916/https://rheum.ca/wp-content/uploads/2022/01/CRA_20-21_AnnualReport_EN.pdf ↩︎

  95. Our Partners. CSN/SCN. Retrieved January 8, 2022, from http://archive.today/2022.01.08-161403/https://www.csnscn.ca/our-partners/ ↩︎

  96. Organizations - FY2013. CDC Foundation. Retrieved August 8, 2022, from https://web.archive.org/web/20220809072921/https://www.cdcfoundation.org/FY2013/organizations ↩︎

  97. Our Supporters 2013. Center for American Progress. Retrieved November 22, 2022, from https://web.archive.org/web/20221122083437/https://www.americanprogress.org/c3-our-supporters-2013/ ↩︎

  98. CAMHF 2020–21 Annual Report Donor Listing. (2021, March 31). Centre for Addiction and Mental Health. Retrieved June 29, 2021, from https://web.archive.org/web/20210629150832/https://www.camh.ca/-/media/files/camhf-2020-21-annual-report-donor-listing.pdf ↩︎

  99. Donor List - Annual Report 2020-2021. CHU Sainte-Justine Foundation. Retrieved March 21, 2022, from https://web.archive.org/web/20220322003700/https://donateurs.fondationstejustine.org/2020-21/?lang=en-CA ↩︎

  100. Our Partnerships. (2021). Colorectal Cancer Canada. https://web.archive.org/web/20220516082302/https://www.colorectalcancercanada.com/what-we-do/our-partnerships/ ↩︎

  101. Home. CQDM - Consortium de Recherche Biopharmaceutique. Retrieved September 13, 2022, from http://archive.today/2022.09.13-150313/https://cqdm.org/en/ ↩︎

  102. Meet Our Partners. Crohn’s & Colitis Foundation. Retrieved October 16, 2022, from http://archive.today/2022.10.16-023856/https://www.crohnscolitisfoundation.org/about/meet-our-partners ↩︎

  103. Benz Jr., E. J., Paresky, S. S., Dana III, C. A., & Morse, R. P. 2012 Honor Roll of Donors. PageTurnPro; Dana-Farber Cancer Institute. Retrieved August 13, 2022, from https://web.archive.org/web/20220813072451/https://www.pageturnpro.com/Dana-Farber-Cancer-Institute-and-The-Jimmy-Fund/49214-2012-Honor-Roll-of-Donors/sdefault.html#page/76 ↩︎

  104. Dreyfuss, R. (2001, December 19). How the DLC Does It. The American Prospect. https://web.archive.org/web/20240419104100/https://prospect.org/features/dlc/ ↩︎

  105. Corporate recognition. Diabetes Canada. Retrieved April 30, 2022, from http://archive.today/2022.05.01-062929/https://www.diabetes.ca/get-involved/corporate-partnerships/corporate-recognition ↩︎

  106. Why sponsor the EURObservational Registry Programme. European Society of Cardiology. Retrieved June 15, 2022, from http://archive.today/2022.06.15-200912/https://www.escardio.org/Research/Registries-&-surveys/Sponsorship ↩︎

  107. 2019 Donors. FNIH 2019 Annual Report. Retrieved April 4, 2022, from https://web.archive.org/web/20211008071205/https://2019-annual-report.fnih.org/donors/ ↩︎

  108. Who We Are. Global Liver Institute. Retrieved July 10, 2023, from https://web.archive.org/web/20230710042334/https://globalliver.org/who-we-are/ ↩︎

  109. Benefactors of Health Level Seven. HL7 International. Retrieved June 7, 2010, from https://web.archive.org/web/20100607033013/http://www.hl7.org/about/benefactors.cfm ↩︎

  110. Block, T. M., & Rosen, J. 2014 Annual Report. Hepatitis B Foundation. Retrieved July 12, 2019, from https://web.archive.org/web/20190712135553/http://www.hepb.org/assets/PDFs/2014-Hep-B-Foundation-Annual-Report.pdf ↩︎

  111. Stern, W. P., & London, H. I. (2003, January 1). 2002 Hudson Institute Annual Report. Hudson Institute. https://web.archive.org/web/20130923185459/http://www.hudson.org/files/publications/Hudson2002AnnualReportFinal.pdf ↩︎

  112. Our Corporate Partners. Junior Diabetes Research Foundation. Retrieved March 11, 2022, from http://archive.today/2022.03.12-033411/https://www.jdrf.ca/who-we-are/our-corporate-partners/ ↩︎

  113. Wu, Y. MaRS Donor Report April 1, 2021 - March 31, 2022. MaRS Discovery District. Retrieved January 22, 2023, from https://web.archive.org/web/20230122160648/https://marsdd-public-files.s3.ca-central-1.amazonaws.com/wp-content/uploads/2019/03/16044948/MaRS-Donor-Report-FY2022.pdf ↩︎

  114. Mayrand, R., & Côté, J.-F. (2023). Rapport annuel 2022/2023. Montreal Clinical Research Institute. https://web.archive.org/web/20240208033438/https://cdn.ca.yapla.com/company/CPY7p4CO2sE1afW3ImwiLyBND/asset/files/_Rapports-annuels/RA_2023_FR.pdf ↩︎

  115. Our Supporters. Mood Disorders Association of Ontario. Retrieved March 1, 2022, from https://archive.ph/ZWXhR ↩︎

  116. Gillison, Jr., D. H. 2020 Annual Report: You are Not Alone. National Alliance on Mental Illness. Retrieved August 2, 2022, from https://web.archive.org/web/20220802062108/https://www.nami.org/NAMI/media/NAMI-Media/PDFs/Financials/NAMI-2020AnnualReport-FINAL.pdf ↩︎

  117. National Partnership for Women & Families. (2019). Our Strength Is in Our Unity. Flipsnack. https://www.flipsnack.com/nationalpartnership/our-strength-is-in-our-unity/full-view.html ↩︎

  118. Our Funders. National Press Foundation. Retrieved January 28, 2013, from https://web.archive.org/web/20130128213106/http://nationalpress.org/about/our-funders/ ↩︎

  119. Annual report 2017–2018. (2018). New Brunswick Health Research Foundation. https://web.archive.org/web/20220328030827/https://nbhrf.com/wp-content/uploads/2021/11/NBHRF-Annual-Report-English.pdf ↩︎

  120. Donor Wall. Northern Ontario School of Medicine. Retrieved July 7, 2022, from https://web.archive.org/web/20220707132244/https://www.nosm.ca/advancement/giving/yourimpact/donor-wall/ ↩︎

  121. Hylands, J. (Ed.). (2005, March). “We would like to acknowledge and thank our sponsors and exhibitors for their support of the Annual Meeting.” Dialogue, March 2005, 11. Ontario Psychiatric Association. https://web.archive.org/web/20220502040455/https://www.eopa.ca/sites/default/uploads/files/DialogueNL_Mar2005.pdf ↩︎

  122. Jüni, P. (2021). Declaration of Interest. Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20241208105006/https://covid19-sciencetable.ca/wp-content/uploads/2020/08/Declaration-of-Interest_Science-Table_Peter-Juni7_20210702.pdf ↩︎

  123. Peter Andrew McCullough. Open Payments Data - CMS. Retrieved February 2, 2024, from https://openpaymentsdata.cms.gov/physician/335114 ↩︎

  124. Plump, A., & Miller, A. M. (2022, June). 2021 Annual Report. PhRMA Foundation. https://web.archive.org/web/20230219205032/https://www.phrmafoundation.org/wp-content/uploads/2022/06/PhRMAFoundation_2021AnnualReport.pdf ↩︎

  125. 2021 Annual Report. The Princess Margaret Cancer Foundation. Retrieved April 19, 2022, from https://web.archive.org/web/20211120191604/https://thepmcf.ca/getmedia/9b96649e-83ba-490a-bacc-f961904b94c8/Annual-Report-2021_Digital.pdf ↩︎

  126. Hicks, C. Annual Report 2009. Pulmonary Hypertension Association. Retrieved August 24, 2014, from https://web.archive.org/web/20140824114725/http://www.phassociation.org/document.doc?id=46 ↩︎

  127. Annual Report 2019 (p. 23). (2019). Reagan-Udall Foundation. https://web.archive.org/web/20220712071448/https://reaganudall.org/sites/default/files/2022-02/Reagan-Udall_Annual Report 20219_final_corrected.pdf ↩︎

  128. Verma, S., Bucci, C., Choi, R., & Gupta, A. (2020, June 12). Navigating Vascular Protective Strategies in HighRisk Patients During the Current Era: Practical Applications. CardioVascUpdate. https://web.archive.org/web/20210304170904/https://cardiovascupdate.ca/files/2020/CV Update Symposium-Presentation.pdf ↩︎

  129. Our Donors. Scarborough Health Network Foundation. Retrieved September 19, 2021, from https://web.archive.org/web/20210919131446/https://www.shnfoundation.ca/our-donors/ ↩︎

  130. 2020-21 SickKids Annual Report. SickKids Foundation. Retrieved January 20, 2022, from http://archive.today/2022.01.20-213118/https://web.sickkidsfoundation.com/annual-report-2020/ ↩︎

  131. 2021-2022 Donors and Event Sponsors. Sigma Theta Tau. Retrieved April 17, 2023, from https://web.archive.org/web/20230417204220/https://www.sigmanursing.org/why-sigma/sigma-foundation-for-nursing/donors-like-you/2021-2022-donors-and-event-sponsors ↩︎

  132. Donor List - 2020-2021. Sinai Health Annual Report. Retrieved May 16, 2022, from https://web.archive.org/web/20230113233706/https://www.sinaihealthannualreport.ca/donor-list-2020-2021 ↩︎

  133. About. Springboard Enterprises. Retrieved March 5, 2023, from https://web.archive.org/web/20230305034408/https://sb.co/about-us/ ↩︎

  134. Our donors. Sunnybrook Foundation. Retrieved January 13, 2022, from https://web.archive.org/web/20220113214441/https://sunnybrook.ca/foundation/your-impact/our-donors-2021.html ↩︎

  135. More of Our Partners. United Nations Foundation. Retrieved October 1, 2023, from https://web.archive.org/web/20231001222831/https://unfoundation.org/who-we-are/our-partners/more-of-our-partners-2/ ↩︎

  136. Presidents’ Circle Member Listing. (2022, May 1). University of Toronto. http://archive.today/2022.05.16-225554/https://engage.utoronto.ca/site/SPageServer?pagename=presidents_circle_member_listing ↩︎

  137. Corporate Sponsors. Darden School. Retrieved August 19, 2000, from http://archive.today/2000.08.19-021013/http://www.darden.virginia.edu/corporate/corp_spons.htm ↩︎

  138. Honor Roll of Donors. University of Washington. Retrieved May 26, 2022, from https://web.archive.org/web/20220610164520/https://uw-s3-cdn.s3.us-west-2.amazonaws.com/wp-content/uploads/sites/83/2020/10/29094302/RTC_HonorRoll_2020.pdf ↩︎

  139. 2018-2019 Annual Report - Donors. Wikimedia Foundation. Retrieved June 27, 2024, from https://web.archive.org/web/20240627202914/https://wikimediafoundation.org/about/annualreport/2019-annual-report/donors/#section-5 ↩︎

  140. 2019 Donors. Wilson Center. Retrieved August 9, 2020, from https://web.archive.org/web/20200809135351/https://www.wilsoncenter.org/2019-donors ↩︎

  141. Voluntary contributions by fund and by contributor, 2018. (2019, May 9). World Health Organization. https://web.archive.org/web/20220613194959/https://apps.who.int/iris/bitstream/handle/10665/329246/A72_INF5-en.pdf ↩︎

  142. Sponsors. World Neuroscience Innovation Forum. Retrieved June 14, 2022, from http://archive.today/2022.06.15-052144/https://neuroscienceinnovationforum.org/sponsors/ ↩︎